This study presents the first comprehensive evaluation of SPDEF gene CpG dinucleotide methylation as a potential epigenetic biomarker associated with prostate cancer (PCa) progression, defined by tumor stage and histological grade. This evidence concerns the gene SPDEF and prostate carcinoma.